We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.18B
AUM Growth
-$490M
Cap. Flow
-$405M
Cap. Flow %
-7.82%
Top 10 Hldgs %
64.56%
Holding
133
New
7
Increased
36
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$164M
2
FRC
First Republic Bank
FRC
+$32.8M
3
C icon
Citigroup
C
+$32.7M
4
TSM icon
TSMC
TSM
+$16.8M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$11.5M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$269M
2
MCK icon
McKesson
MCK
+$226M
3
V icon
Visa
V
+$95.7M
4
CVS icon
CVS Health
CVS
+$17.5M
5
META icon
Meta Platforms (Facebook)
META
+$14.5M

Sector Composition

Rank Sector Weight
1 Financials 26.52%
2 Healthcare 19.99%
3 Consumer Discretionary 17.87%
4 Communication Services 13.4%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
51
Weyerhaeuser
WY
$17.6B
$6.22M 0.12%
206,584
+112,045
+119% +$3.45M
KO icon
52
Coca-Cola
KO
$387B
$5.6M 0.11%
135,060
+73,447
+119% +$3.06M
ZBH icon
53
Zimmer Biomet
ZBH
$18.6B
$5.29M 0.1%
52,785
+1,285
+2% +$138K
ABBV icon
54
AbbVie
ABBV
$470B
$5.06M 0.1%
80,825
-26,675
-25% -$1.63M
COR icon
55
Cencora
COR
$62B
$4.84M 0.09%
61,900
-3,200
-5% -$250K
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$4.78M 0.09%
69,495
-23,806
-26% -$1.71M
ALXN
57
DELISTED
Alexion Pharmaceuticals
ALXN
$4.73M 0.09%
38,664
-5,897
-13% -$722K
HZNP
58
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.59M 0.09%
283,640
-463,960
-62% -$8.41M
PODD icon
59
Insulet
PODD
$11.7B
$4.45M 0.09%
118,000
+10,000
+9% +$373K
EGRX
60
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4.25M 0.08%
53,600
-29,807
-36% -$2.17M
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$2.49B
$3.81M 0.07%
54,225
-21,275
-28% -$1.51M
AIRM
62
DELISTED
Air Methods Corp
AIRM
$3.54M 0.07%
111,000
-5,000
-4% -$154K
BHC icon
63
Bausch Health
BHC
$1.68B
$3.11M 0.06%
214,021
-10,440
-5% -$192K
TVRD
64
Tvardi Therapeutics
TVRD
$22.1M
$2.97M 0.06%
8,884
+1,440
+19% +$462K
MA icon
65
Mastercard
MA
$502B
$2.92M 0.06%
28,300
+500
+2% +$51.8K
KITE
66
DELISTED
Kite Pharma, Inc.
KITE
$2.87M 0.06%
63,904
-9,096
-12% -$446K
ZLTQ
67
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.83M 0.05%
65,000
-70,000
-52% -$2.82M
ONCE
68
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.78M 0.05%
55,666
-10,134
-15% -$543K
DXCM icon
69
DexCom
DXCM
$29.1B
$2.77M 0.05%
185,700
+24,000
+15% +$425K
AERI
70
DELISTED
Aerie Pharmaceuticals
AERI
$2.73M 0.05%
72,083
-69,417
-49% -$2.63M
SPNC
71
DELISTED
Spectranetics Corp
SPNC
$2.69M 0.05%
110,000
-49,956
-31% -$1.18M
CHRS icon
72
Coherus Oncology
CHRS
$217M
$2.67M 0.05%
94,676
-62,124
-40% -$1.74M
SUPN icon
73
Supernus Pharmaceuticals
SUPN
$2.72B
$2.6M 0.05%
103,000
-20,000
-16% -$447K
PTLA
74
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.56M 0.05%
114,180
-11,933
-9% -$233K
CEMP
75
DELISTED
Cempra, Inc.
CEMP
$2.5M 0.05%
891,974
-4,826
-0.5% -$58.5K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2016 Portfolio in Review

As of Q4 2016, C WorldWide Group held 133 positions worth $5.18B, down 8.6% from $5.67B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

C WorldWide Group withdrew a net $405M in Q4 2016, closing 9 positions and reducing 60 holdings. Its most notable exit was McKesson, an estimated $226M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, C WorldWide Group opened a new position in Philip Morris worth $162M.

  • C WorldWide Group's largest Q4 2016 buy was Philip Morris: 1,771,417 shares worth $162M.
  • C WorldWide Group added most to First Republic Bank in Q4 2016, an estimated $32.8M increase.
  • C WorldWide Group's biggest Q4 2016 reduction was Dollar General, cutting an estimated $269M.
  • C WorldWide Group fully exited McKesson in Q4 2016, selling an estimated $226M.
  • C WorldWide Group's ten largest holdings make up 65% of its $5.18B portfolio in Q4 2016.
  • C WorldWide Group opened 7 new positions and closed 9 in Q4 2016.
  • C WorldWide Group's portfolio value fell 8.6% quarter-over-quarter to $5.18B.

Based on C WorldWide Group's 13F filing for Q4 2016, filed 6 Feb 2017.